Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function

BACKGROUND AND OBJECTIVE: This study measured and compared the exposure and safety of peficitinib (ASP015K), a novel oral Janus kinase inhibitor, in subjects with normal and impaired renal function after a single oral, clinically relevant peficitinib dose. METHODS: This was an open-label, parallel-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyatake, Daisuke, Shibata, Tomohisa, Shibata, Mai, Kaneko, Yuichiro, Oda, Kazuo, Nishimura, Tetsuya, Katashima, Masataka, Sekino, Hisakuni, Furihata, Kenichi, Urae, Akinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989572/
https://www.ncbi.nlm.nih.gov/pubmed/31729626
http://dx.doi.org/10.1007/s40261-019-00873-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989572/
https://www.ncbi.nlm.nih.gov/pubmed/31729626
http://dx.doi.org/10.1007/s40261-019-00873-7

Ejemplares similares